Latest Us Market News

Stakk Limited reveals a striking 566% year-to-date growth in annual recurring revenue, driven by its pivot to a B2B embedded finance platform and strategic US market expansion. The company also secured a $15 million institutional placement, underpinning its ambitious growth plans.

Talga Group has successfully raised A$14.5 million through a placement to accelerate its anode production scale-up and explore expansion opportunities in the US, supported by a significant Swedish government grant.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

Summit Minerals has agreed to acquire the historic Keystone Mine in Nevada, a polymetallic project boasting impressive historic grades of silver, gold, and tungsten. The acquisition positions Summit to tap into a prolific US mining district with significant critical metals potential.

Ovanti Limited’s US subsidiary has secured a key partnership with Mastercard’s Finicity to enhance its upcoming Flote BNPL platform, aiming to revolutionize consumer finance with real-time data insights.

Mandrake Resources has inked a binding agreement with DISA Technologies to recover uranium and critical minerals from abandoned mine waste across its expansive Utah Project, tapping into a growing US government-backed market.

Savana Asset Management marks the first anniversary of its Savana US Small Caps Active ETF (ASX, SVNP), reporting a strong 13.62% annualised return that outpaced its benchmark despite a volatile US market. The firm also reveals insights from a novel AI stress test highlighting current limitations of large language models in investment decision-making.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

RMA Global Limited reveals its strategic push into the US market, leveraging its Local Expert Marketing platform to capture a significant share of the real estate marketing sector.

4DMedical has expanded its partnership with Philips, securing a US$10 million order commitment to distribute its CT – VQ™ lung imaging technology across North America, aiming to transform pulmonary diagnostics.

LTR Pharma has secured ethics approval for its Phase II SPONTAN clinical trial, focusing on pharmacokinetics and dosing in men aged 65 and older. Recruitment begins early 2026 with initial results expected mid-year.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.